BeStock  
Markets › Compare › GLUE vs LZ

GLUE vs LZ

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GLUE · Monte Rosa Therapeutics$8.64 ▼ 3.03%
LZ · LegalZoom$4.47 ▼ 1.97%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4273105136167Nov 24, '25May 26, '26Nov 20, '26
  • GLUE -45.2%
  • LZ -51.3%

Head to head

MetricGLUELZ
Price$8.64$4.47
Change today▼ 3.03%▼ 1.97%
Market cap$738.29M$738.26M
Return, 3 months-37.3%-25.5%
Return, year to date-44.9%-55.0%
Return, 1 year-39.2%-50.9%
P/E (TTM)–40.6
P/B1.55.5
P/E percentile vs own 5y11th41st
Dividend yield––
Revenue growth (YoY, latest qtr)+325.8%+2.6%
Net profit growth (YoY)+111.3%+78.8%
Gross margin–67.6%
Operating margin-214.5%5.0%
Net margin-186.2%2.6%
Return on equity-35.3%12.1%
Analyst target vs. price+191.0%+28.6%
Analyst buy share100%0%
RSI (14)2729
30-day volatility58.3%76.0%
Max drawdown, 1 year-65.9%-57.0%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuySell

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GLUE is the largest of the group by market value.
  • GLUE has returned the most over the past year.
  • GLUE is growing revenue fastest.
  • LZ keeps the most profit per dollar of sales.
  • GLUE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top